M. A. Asge-standards-of-practice-committeeeloubeidi, G. A. Decker, V. Chandrasekhara, K. V. Chathadi, D. S. Early et al., The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia, Gastrointest Endosc, vol.83, pp.17-28, 2016.

D. Azuara, M. M. Ginesta, M. Gausachs, F. Rodriguez-moranta, J. Fabregat et al., Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer, Clin Chem, vol.58, pp.1332-1341, 2012.

U. K. Ballehaninna and R. S. Chamberlain, The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal, J Gastrointest Oncol, vol.3, pp.105-119, 2012.

C. Bettegowda, M. Sausen, R. J. Leary, I. Kinde, Y. Wang et al., Sci Transl Med, vol.6, pp.224-248, 2014.

E. Beutler, T. Gelbart, and W. Kuhl, Interference of heparin with the polymerase chain reaction, BioTechniques, vol.9, p.166, 1990.

F. C. Bidard, F. Huguet, C. Louvet, L. Mineur, O. Bouché et al., Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial, Ann Oncol, vol.24, pp.2057-2061, 2013.

N. Brychta, T. Krahn, and O. Von-ahsen, Detection of KRAS mutations in circulating tumor DNA by Digital PCR in early stages of pancreatic cancer, Clin Chem, vol.62, pp.1482-1491, 2016.

A. Chan, I. Prassas, A. Dimitromanolakis, R. E. Brand, S. Serra et al., Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer, Clin Cancer Res, vol.20, pp.5787-5795, 2014.

J. Dewitt, P. Jowell, J. Leblanc, L. Mchenry, K. Mcgreevy et al., EUS-guided FNA of pancreatic metastases: a multicenter experience, Gastrointest Endosc, vol.61, pp.689-696, 2005.

L. A. Diaz and A. Bardelli, Liquid biopsies: genotyping circulating tumor DNA, J Clin Oncol, vol.32, pp.579-586, 2014.

J. Earl, S. Garcia-nieto, J. C. Martinez-avila, J. Montans, A. Sanjuanbenito et al., Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer, BMC Cancer, vol.15, p.797, 2015.

M. A. Eloubeidi, V. K. Chen, I. A. Eltoum, D. Jhala, D. C. Chhieng et al., Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications, Am J Gastroenterol, vol.98, pp.2663-2668, 2003.

M. A. Eloubeidi, D. Jhala, D. C. Chhieng, V. K. Chen, I. Eltoum et al., Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma, Cancer, vol.99, pp.285-292, 2003.

S. A. Forbes, D. Beare, H. Boutselakis, S. Bamford, N. Bindal et al., COSMIC: somatic cancer genetics at high-resolution, Nucleic Acids Res, vol.45, pp.777-783, 2017.

P. K. Grover, A. G. Cummins, T. J. Price, I. C. Roberts-thomson, and J. E. Hardingham, Circulating tumor cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research, Ann Oncol, vol.25, pp.1506-1516, 2014.

N. Hadano, Y. Murakami, K. Uemura, Y. Hashimoto, N. Kondo et al., Prognostic value of circulating tumor DNA in patients undergoing curative resection for pancreatic cancer, Br J Cancer, vol.115, pp.59-65, 2016.

G. C. Harewood and M. J. Wiersema, Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses, Am J Gastroenterol, vol.97, pp.1386-1391, 2002.

V. Hofman, E. Long, M. Ilie, C. Bonnetaud, J. M. Vignaud et al., Morphological analysis of circulating tumor cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumor cell (ISET) method, Cytopathology, vol.23, pp.30-38, 2012.

I. Iwanicki-caron, P. Basile, E. Toure, M. Antonietti, S. Lecleire et al., Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis, Am J Gastroenterol, vol.108, pp.152-155, 2013.

J. B. Jackson, D. S. Choi, J. D. Luketich, A. Pennathur, A. Ståhlberg et al., Multiplex preamplification of serum DNA to facilitate reliable detection of extremely rare cancer mutations in circulating DNA by digital PCR, J Mol Diagn, vol.18, pp.235-243, 2016.

T. Kamisawa, L. D. Wood, T. Itoi, and K. Takaori, Pancreatic cancer, Lancet, vol.388, pp.73-85, 2016.

L. Khoja, A. Backen, R. Sloane, L. Menasce, D. Ryder et al., A pilot study to explore circulating tumor cells in pancreatic cancer as a novel biomarker, Br J Cancer, vol.106, pp.508-516, 2012.

H. Kinugasa, K. Nouso, K. Miyahara, Y. Morimoto, C. Dohi et al., Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer, Cancer, vol.121, pp.2271-2280, 2015.

B. Kulemann, M. B. Pitman, A. S. Liss, N. Valsangkar, F. Castillo et al., Circulating tumor cells found in patients with localized and advanced pancreatic cancer, Pancreas, vol.44, pp.547-550, 2015.

T. Kurihara, T. Itoi, A. Sofuni, F. Itokawa, T. Tsuchiya et al., Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result, J Hepatobiliary Pancreat Surg, vol.15, pp.189-195, 2008.

A. Lamy, F. Blanchard, L. Pessot, F. Sesboüé, R. et al., Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls, Mod Pathol, vol.24, pp.1090-1100, 2011.

J. K. Leblanc, D. Ciaccia, M. T. Al-assi, K. Mcgrath, T. Imperiale et al., Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis, Gastrointest Endosc, vol.59, pp.475-481, 2004.

A. Nouts, P. Lévy, H. Voitot, and P. Bernades, Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma, Gastroenterol Clin Biol, vol.22, pp.152-159, 1998.

K. E. Poruk, V. Valero, T. Saunders, A. L. Blackford, J. F. Griffin et al., Circulating tumor cell phenotype predicts recurrence and survival in pancreatic adenocarcinoma, Ann Surg, vol.264, pp.1073-1081, 2016.

M. Sausen, J. Phallen, V. Adleff, S. Jones, R. J. Leary et al., Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients, Nat Commun, vol.6, p.7686, 2015.

D. Sefrioui, A. Perdrix, N. Sarafan-vasseur, C. Dolfus, A. Dujon et al.,

D. Fiore, F. Clatot, and F. , Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer, Int J Cancer, vol.137, pp.2513-2519, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02353282

D. Sefrioui, N. Sarafan-vasseur, L. Beaussire, M. Baretti, A. Gangloff et al., Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer, Dig Liver Dis, vol.47, pp.884-890, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02353257

N. Singh, S. Gupta, R. M. Pandey, S. S. Chauhan, and A. Saraya, High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival, Cancer Invest, vol.33, pp.78-85, 2015.

B. Slesak, A. Harlozinska-szmyrka, W. Knast, P. Sedlaczek, A. Van-dalen et al., Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9, Cancer, vol.89, pp.83-88, 2000.

W. Steinberg, The clinical utility of the CA 19-9 tumor-associated antigen, Am J Gastroenterol, vol.85, pp.350-355, 1990.

S. Su, S. Qin, W. Chen, W. Luo, and H. Jiang, Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis, World J Gastroenterol, vol.21, pp.4323-4333, 2015.

A. D. Sweeney, M. Wu, S. G. Hilsenbeck, F. C. Brunicardi, and W. E. Fisher, Value of pancreatic resection for cancer metastatic to the pancreas, J Surg Res, vol.156, pp.189-198, 2009.

M. Tadic, M. Kujundzic, T. Stoos-veic, G. Kaic, and M. Vukelic-markovic, Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings, Dig Dis, vol.26, pp.377-382, 2008.

E. Takai, Y. Totoki, H. Nakamura, C. Morizane, S. Nara et al., Clinical utility of circulating tumor DNA for molecular assessment in pancreatic, cancer. Sci Rep, vol.5, p.18425, 2015.

H. Uehara, K. Ikezawa, N. Kawada, N. Fukutake, K. Katayama et al., Diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic malignancy in relation to the size of lesions, J Gastroenterol Hepatol, vol.26, pp.1256-1261, 2011.

S. Varadarajulu, A. Tamhane, and M. A. Eloubeidi, Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis, Gastrointest Endosc, vol.62, pp.728-736, 2005.

M. Visani, D. De-biase, P. Baccarini, C. Fabbri, A. M. Polifemo et al., Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of divergent populations of tumor cells, Int J Surg Pathol, vol.21, pp.546-552, 2013.

P. Wang, A. Bahreini, R. Gyanchandani, P. Lucas, R. J. Hartmaier et al., Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions and cell free DNA of breast cancer patients, Clin Cancer Res, vol.22, pp.1130-1137, 2015.

J. M. Winter, C. J. Yeo, and J. R. Brody, Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer, J Surg Oncol, vol.107, pp.15-22, 2013.

S. Yoshinaga, H. Suzuki, I. Oda, and Y. Saito, Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses, Dig Endosc, vol.23, issue.1, pp.29-33, 2011.

O. A. Zill, C. Greene, D. Sebisanovic, L. M. Siew, J. Leng et al., Cell-Free DNA next-generation sequencing in pancreatobiliary carcinomas, Cancer Discov, vol.5, pp.1040-1048, 2015.